Migraine and risk of cardiovascular disease in women

被引:421
作者
Kurth, Tobias
Gaziano, J. Michael
Cook, Nancy R.
Logroscino, Giancarlo
Diener, Hans-Christoph
Buring, Julie E.
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Aging, Boston, MA USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Boston VA Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA
[5] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA
[6] Univ Duisburg Essen, Dept Neurol, Essen, Germany
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 296卷 / 03期
关键词
D O I
10.1001/jama.296.3.283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Migraine with aura has been associated with an adverse cardiovascular risk profile and prothrombotic factors that, along with migraine-specific physiology, may increase the risk of vascular events. Although migraine with aura has been associated with increased risk of ischemic stroke, an association with cardiovascular disease (CVD) and, specifically, coronary events remains unclear. Objective To evaluate the association between migraine with and without aura and subsequent risk of overall and specific CVD. Design, Setting, and Participants Prospective cohort study of 27 840 US women aged 45 years or older who were participating in the Women's Health Study, were free of CVD and angina at study entry (1992-1995), and who had information on self-reported migraine and aura status, and lipid measurements. This report is based on follow-up data through March 31, 2004. Main Outcome Measures The primary outcome measure was the combined end point of major CVD (first instance of nonfatal ischemic stroke, nonfatal myocardial infarction, or death due to ischemic CVD); other measures were first ischemic stroke, myocardial infarction, coronary revascularization, angina, and death due to ischemic CVD. Results At baseline, 5125 women (18.4%) reported any history of migraine; of the 3610 with active migraine (migraine in the prior year), 1434 (39.7%) indicated aura symptoms. During a mean of 10 years of follow-up, 580 major CVD events occurred. Compared with women with no migraine history, women who reported active migraine with aura had multivariable-adjusted hazard ratios of 2.15 (95% confidence interval [CI], 1.58-2.92; P<.001) for major CVD, 1.91 (95% CI, 1.17-3.10; P=.01) for ischemic stroke, 2.08 (95% CI, 1.30-3.31; P=.002) for myocardial infarction, 1.74 (95% CI, 1.23-2.46; P=.002) for coronary revascularization, 1.71 (95% CI, 1.16-2.53; P=.007) for angina, and 2.33 (95% CI, 1.21-4.51; P=.01) for ischemic CVD death. After adjusting for age, there were 18 additional major CVD events attributable to migraine with aura per 10 000 women per year. Women who reported active migraine without aura did not have increased risk of any vascular events or angina. Conclusions In this large, prospective cohort of women, active migraine with aura was associated with increased risk of major CVD, myocardial infarction, ischemic stroke, and death due to ischemic CVD, as well as with coronary revascularization and angina. Active migraine without aura was not associated with increased risk of any CVD event.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 41 条
[21]   Prevalence and burden of migraine in the United States: Data from the American Migraine Study II [J].
Lipton, RB ;
Stewart, WF ;
Diamond, S ;
Diamond, ML ;
Reed, M .
HEADACHE, 2001, 41 (07) :646-657
[22]   Evaluating the safety and tolerability profile of acute treatments for migraine [J].
Martin, VT ;
Goldstein, JA .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 :36S-44S
[23]   Prevalence and vascular associations with migraine in older Australians [J].
Mitchell, P ;
Wang, JJ ;
Currie, J ;
Cumming, RG ;
Smith, W .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (05) :627-632
[24]   Baseline characteristics of participants in the women's health study [J].
Rexrode, KM ;
Lee, IM ;
Cook, NR ;
Hennekens, CH ;
Buring, JE .
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2000, 9 (01) :19-27
[25]   A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women [J].
Ridker, PM ;
Cook, NR ;
Lee, IM ;
Gordon, D ;
Gaziano, JM ;
Manson, JE ;
Hennekens, CH ;
Buring, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) :1293-1304
[26]   Are migraine and coronary heart disease associated? An epidemiologic review [J].
Rosamond, W .
HEADACHE, 2004, 44 :S5-S12
[27]   Migraine and other headaches - Associations with Rose angina and coronary heart disease [J].
Rose, KM ;
Carson, AP ;
Sanford, CP ;
Stang, PE ;
Brown, CA ;
Folsom, AR ;
Szklo, M .
NEUROLOGY, 2004, 63 (12) :2233-2239
[28]   Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) [J].
Rothwell, PM ;
Coull, AJ ;
Silver, LE ;
Fairhead, JF ;
Giles, MF ;
Lovelock, CE ;
Redgrave, JNE ;
Bull, LM ;
Welch, SJV ;
Cuthbertson, FC ;
Binney, LE ;
Gutnikov, SA ;
Anslow, P ;
Banning, AP ;
Mant, D ;
Mehta, Z .
LANCET, 2005, 366 (9499) :1773-1783
[29]   Migraine and MTHFR C677T genotype in a population-based sample [J].
Scher, AI ;
Terwindt, GM ;
Verschuren, WMM ;
Kruit, MC ;
Blom, HJ ;
Kowa, H ;
Frants, RR ;
van den Maagdenberg, AMJM ;
van Buchem, M ;
Ferrari, MD ;
Launer, LJ .
ANNALS OF NEUROLOGY, 2006, 59 (02) :372-375
[30]   Cardiovascular risk factors and migraine - The GEM population-based study [J].
Scher, AI ;
Terwindt, GM ;
Picavet, HSJ ;
Verschuren, WMM ;
Ferrari, MD ;
Launer, LJ .
NEUROLOGY, 2005, 64 (04) :614-620